Advances in Medicinal Chemistry for Drug Discovery and Development
A special issue of AppliedChem (ISSN 2673-9623).
Deadline for manuscript submissions: 31 May 2026 | Viewed by 191
Special Issue Editor
Interests: anticancer; heterocyclic compounds; small molecules; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
While remarkable progress has been made in combating many diseases, the global burden of cancer, cardiovascular and cerebrovascular diseases, and diabetes continues to grow. For these conditions, gaps in our understanding of pathogenesis, along with limitations in current medical technologies, continue to pose significant challenges. Thus, innovative approaches and novel next-generation drugs are urgently needed. Natural products and designed small heterocyclic molecules remain invaluable in this effort, forming the basis of most drugs used in clinical practice. We invite researchers to contribute original studies and insightful reviews that highlight breakthroughs, opportunities, and challenges in harnessing natural and designed molecules for drug discovery.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Discovery of novel natural and synthesized drug molecules;
- Structural determination of bioactive molecules;
- Advances in the application of established molecules in drug discovery;
- Computer-aided drug design and molecular modeling approaches;
- Structure–activity relationship (SAR) studies between molecules and their biological targets.
Dr. Suresh Narva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. AppliedChem is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer
- heterocyclic compounds
- small molecules
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
